125 related articles for article (PubMed ID: 37549694)
21. Coffee consumption and the risk of venous thromboembolism: the Tromsø study.
Enga KF; Braekkan SK; Hansen-Krone IJ; Wilsgaard T; Hansen JB
J Thromb Haemost; 2011 Jul; 9(7):1334-9. PubMed ID: 21592303
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19.
Xie J; Prats-Uribe A; Feng Q; Wang Y; Gill D; Paredes R; Prieto-Alhambra D
JAMA Intern Med; 2022 Oct; 182(10):1063-1070. PubMed ID: 35980616
[TBL] [Abstract][Full Text] [Related]
23. Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow-up study.
Vučković BA; Cannegieter SC; van Hylckama Vlieg A; Rosendaal FR; Lijfering WM
J Thromb Haemost; 2017 Jul; 15(7):1430-1435. PubMed ID: 28439955
[TBL] [Abstract][Full Text] [Related]
24. Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
Hansen ES; Rinde FB; Edvardsen MS; Hindberg K; Latysheva N; Aukrust P; Ueland T; Michelsen AE; Hansen JB; Brækkan SK; Morelli VM
Thromb Res; 2021 Dec; 208():121-126. PubMed ID: 34763296
[TBL] [Abstract][Full Text] [Related]
25. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway.
Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
J Thromb Haemost; 2010 Jan; 8(1):157-62. PubMed ID: 19496920
[TBL] [Abstract][Full Text] [Related]
26. Obesity measures and risk of venous thromboembolism and myocardial infarction.
Horvei LD; Brækkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
Eur J Epidemiol; 2014 Nov; 29(11):821-30. PubMed ID: 25213403
[TBL] [Abstract][Full Text] [Related]
27. Association between body mass index, waist circumference, and relative fat mass with the risk of first unprovoked venous thromboembolism.
Caiano LM; Costanzo S; Panzera T; Di Castelnuovo A; de Gaetano G; Donati MB; Ageno W; Iacoviello L;
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3122-3130. PubMed ID: 34629257
[TBL] [Abstract][Full Text] [Related]
28. Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.
Horvei LD; Brækkan SK; Hansen JB
PLoS One; 2016; 11(12):e0168878. PubMed ID: 27997594
[TBL] [Abstract][Full Text] [Related]
29. The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Tromsø study.
Blix K; Brækkan SK; le Cessie S; Skjeldestad FE; Cannegieter SC; Hansen JB
Eur J Epidemiol; 2014 Apr; 29(4):277-84. PubMed ID: 24748425
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.
Edvardsen MS; Hindberg K; Hansen ES; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
Blood Adv; 2021 Jan; 5(1):224-232. PubMed ID: 33570640
[TBL] [Abstract][Full Text] [Related]
31. Prepregnancy overweight and obesity and long-term risk of venous thromboembolism in women.
Mahmoud A; Sandblad KG; Lundberg CE; Hellsén G; Hansson PO; Adiels M; Rosengren A
Sci Rep; 2023 Sep; 13(1):14597. PubMed ID: 37670016
[TBL] [Abstract][Full Text] [Related]
32. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
[TBL] [Abstract][Full Text] [Related]
33. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of venous thromboembolism in the Framingham Heart Study.
Puurunen MK; Gona PN; Larson MG; Murabito JM; Magnani JW; O'Donnell CJ
Thromb Res; 2016 Sep; 145():27-33. PubMed ID: 27442716
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
36. Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.
Frischmuth T; Hindberg K; Aukrust P; Ueland T; Brækkan SK; Hansen JB; Morelli VM
Thromb Haemost; 2022 Apr; 122(4):560-569. PubMed ID: 34264516
[TBL] [Abstract][Full Text] [Related]
37. Overall and abdominal obesity in relation to venous thromboembolism.
Yuan S; Bruzelius M; Xiong Y; Håkansson N; Åkesson A; Larsson SC
J Thromb Haemost; 2021 Feb; 19(2):460-469. PubMed ID: 33179380
[TBL] [Abstract][Full Text] [Related]
38. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
39. Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort.
French SA; Lutsey PL; Rosamond W; MacLehose RF; Cushman M; Folsom AR
Int J Obes (Lond); 2020 Dec; 44(12):2465-2471. PubMed ID: 32948842
[TBL] [Abstract][Full Text] [Related]
40. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Enga KF; Jorde R; Schirmer H; Njølstad I; Svartberg J; Braekkan SK; Hansen JB
J Thromb Haemost; 2014; 12(3):313-9. PubMed ID: 24382156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
